Concord Drugs Limited, founded in 1995, is a leading pharmaceutical company in India. Specializing in generics, branded, and specialty pharmaceuticals, Concord is known for its diverse product portfolio of over 200 prescription and over-the-counter products.

Concord Drugs major competitors are Shanmuga Hospital, Godavari Drugs, Vista Pharma, Accretion Pharma., Biofil Chem & Pharma, Bacil Pharma, Medistep Healthcare.
Market Cap of Concord Drugs is ₹63 Crs.
While the median market cap of its peers are ₹62 Crs.

Concord Drugs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.